|
|
| Research article summary (published 21 Sep 2009): |
Nanoparticles can induce changes in the intracellular metabolism of lipids without compromising cellular viability.
Full Abstract
There is growing concern about the safety of engineered nanoparticles, which are produced for various industrial applications. Quantum dots are colloidal semiconductor nanoparticles that have unique luminescence characteristics and the potential to become attractive tools for medical imaging. However, some of these particles can cause oxidative stress and induce cell death. The objective of this study was to explore quantum dot-induced metabolic changes, which could occur without any apparent cellular damage. We provide evidence that both uncoated and ZnS-coated quantum dots can induce the accumulation of lipids (increase in cytoplasmic lipid droplet formation) in two cell culture models: glial cells in primary mouse hypothalamic cultures and rat pheochromocytoma PC12 cells. Glial cells treated with CdTe quantum dots accumulated newly synthesized lipids in a phosphoinositide 3-kinase-dependent manner, which was consistent with the growth factor-dependent accumulation of lipids in PC12 cells treated with CdTe and CdSe/ZnS quantum dots. In PC12 cells, quantum dots, as well as the hypoxia mimetic CoCl(2), induced the up-regulation of hypoxia-inducible transcription factor-1alpha and the down-regulation of the beta-oxidation of fatty acids, both of which could contribute to the accumulation of lipids. On the basis of our results, we propose a model illustrating how nanoparticles, such as quantum dots, could trigger the formation of intracellular lipid droplets, and we suggest that metabolic measurements, such as the determination of fat oxidation in tissues, which are known sites of nanoparticle accumulation, could provide useful measures of nanoparticle safety. Such assays would expand the current platform of tests for the determination of the biocompatibility of nanomaterials.
Author information
Author/s: Przybytkowski, Ewa (E); Behrendt, Maik (M); Dubois, David (D); Maysinger, Dusica (D);
Affiliation: Department of Pharmacology and Therapeutics, McGill University, Montréal, Canada.
Journal and publication information
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal: The FEBS journal (FEBS J), published in England. (Language: eng)
Reference: 2009-Nov; vol 276 (issue 21) : pp 6204-17
Dates: Created 2009/10/14; Completed 2009/10/28;
PMID: 19780838, status: MEDLINE (last retrieved date: 10/28/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Fatty Acids, Nonesterified (0) ; 1-Phosphatidylinositol 3-Kinase (EC 2.7.1.137)Related articles
These are the most related articles currently in our database:
- Toxicity assessment of manufactured nanomaterials using the unicellular green alga Chlamydomonas reinhardtii.
31 Aug 2008 - Computational and ultrastructural toxicology of a nanoparticle, Quantum Dot 705, in mice.
13 Aug 2008 - Aqueous toxicity and food chain transfer of Quantum DOTs in freshwater algae and Ceriodaphnia dubia.
30 Aug 2008 - Nanotoxicity: the growing need for in vivo study.
19 Dec 2007 - Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles.
17 Jul 2007 - Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments.
8 Nov 2006 - [Carbon nanotubes (CNT) and nanoparticles (NP): interaction with lung epithelium and other biological systems]
29 Jun 2006 - Nanoparticle analysis and characterization methodologies in environmental risk assessment of engineered nanoparticles.
14 May 2008 - Application of a pilot control banding tool for risk level assessment and control of nanoparticle exposures.
14 Jul 2008 - Nanotoxicity of iron oxide nanoparticle internalization in growing neurons.
9 Feb 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.